Therapeutic enzymes as non-conventional targets in cardiovascular impairments: A comprehensive review.

Kumar, Gaurav; Saini, Manisha; Kundu, Suman

Kumar, Gaurav; Saini, Manisha; Kundu, Suman.

Affiliation

Kumar G; Department of Biochemistry, University of Delhi South Campus, New Delhi-110021, India.
Saini M; Department of Biochemistry, University of Delhi South Campus, New Delhi-110021, India.
Kundu S; Department of Biochemistry, University of Delhi South Campus, New Delhi-110021, India.

Can J Physiol Pharmacol ; 100(3): 197-209, 2022 Mar.

Article in En | MEDLINE | ID: mdl-34932415

Subject(s)

Cardiovascular Diseases/drug therapy; Cardiovascular Diseases/enzymology; Molecular Targeted Therapy; Antioxidants; Arginase; Cardiotonic Agents; Cardiovascular Diseases/etiology; Cytochrome-B(5) Reductase; Dopamine beta-Hydroxylase; Epoxide Hydrolases; Female; Humans; Male; Matrix Metalloproteinases; Middle Aged; NADPH Oxidases; Phosphoric Diester Hydrolases; Selenoproteins; Superoxide Dismutase; Thioredoxin-Disulfide Reductase; Xanthine Dehydrogenase

Key words

cardiovascular diseases; cardiovascular impairments; inhibiteurs; inhibitors; maladies cardiovasculaires; therapeutic enzymes; traitements enzymatiques; troubles cardiovasculaires

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Cardiovascular Diseases / Molecular Targeted Therapy Type of study: Etiology_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Can J Physiol Pharmacol Year: 2022 Type: Article Affiliation country: India

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google